Annual R&D Expenses -- $41.1 million in 2025, a 19% decrease driven primarily by a $4.5 million reduction in lab and ...
Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...
Good afternoon, everyone, and thank you for joining us. Before we get into the results for the quarter, we are excited to discuss our just announced strategic partnership with Starwood Digital ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Good morning, ladies and gentlemen, and welcome to the Arcosa, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. My name is Chloe and I will be your conference call coordinator today.
Operator: Good morning. Welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2025 Conference Call. Please be ...
Gray Media, Inc. (NYSE:GTN) Q4 2025 Earnings Call Transcript February 26, 2026 Gray Media, Inc. beats earnings expectations. Reported EPS is $-0.10309, expectations were $-0.28. Operator: Good day, ...
2026 Revenue and EBITDA Guidance -- Revenues of $1,800,000,000-$2,000,000,000 and EBITDA of $800,000,000-$1,000,000,000, assuming gold at $4,500, silver at $70, and copper at $12,000 (no further ...
WASHINGTON (AP) — Former Secretary of State Hillary Clinton told members of Congress on Thursday that she had no knowledge of ...
The following is the transcript of the interview with Christine Lagarde, European Central Bank president, that aired on "Face the Nation with Margaret Brennan" on Feb. 22, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results